Sport and Aortic valve disease

Similar documents
Managing Mitral Regurgitation: Repair, Replace, or Clip? Michael Howe, MD Traverse Heart & Vascular

Low-gradient severe aortic stenosis with normal LVEF: A disturbing clinical entity

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

5. Management of rheumatic heart disease

HEART HEALTH WEEK 3 SUPPLEMENT. A Beginner s Guide to Cardiovascular Disease HEART FAILURE. Relatively mild, symptoms with intense exercise

Management of the Patient with Aortic Stenosis undergoing Non-cardiac Surgery

Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease

Dysfunction of aortic valve prostheses

Original Scientific Paper. Copyright European Society of Cardiology. Unauthorized reproduction of this article is prohibited.

Section Four: Pulmonary Artery Waveform Interpretation

EAE TEACHING COURSE Aorta and aortic valve 2012

RACE I Rapid Assessment by Cardiac Echo. Intensive Care Training Program Radboud University Medical Centre NIjmegen

How To Treat Aortic Stenosis

The P Wave: Indicator of Atrial Enlargement

Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI

Provider Checklist-Outpatient Imaging. Checklist: Nuclear Stress Test, Thallium/Technetium/Sestamibi (CPT Code )

Aortic Valve Stenosis and CAD

HISTORY. Questions: 1. What diagnosis is suggested by this history? 2. How do you explain her symptoms during pregnancy?

Palpitations & AF. Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust

Potential Causes of Sudden Cardiac Arrest in Children

How to read the ECG in athletes: distinguishing normal form abnormal

1p36 and the Heart. John Lynn Jefferies, MD, MPH, FACC, FAHA

INHERIT. The Lancet Diabetes & Endocrinology In press

38 year old female with mild obesity. She is planning an exercise program to loose weight. She has no other known risk factors for CAD.

Diagnostic and Therapeutic Procedures

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary

INTRODUCTION TO EECP THERAPY

NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3

Atrial Fibrillation Based on ESC Guidelines. Moshe Swissa MD Kaplan Medical Center

May 1 6, 2016 Loews Atlanta Hotel Atlanta, GA PRELIMINARY PROGRAM AT A GLANCE

Note: The left and right sides of the heart must pump exactly the same volume of blood when averaged over a period of time

Perioperative Cardiac Evaluation

Steven J. Yakubov, MD FACC For the CoreValve US Clinical Investigators

How To Understand What You Know

Cardiology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Cardiology

Valve Disease and Diastology Summit

Doc, I Am Fine, But I Have A Cardiac Condition

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg

Clinical Commissioning Policy Statement: Percutaneous mitral valve leaflet repair for mitral regurgitation April Reference: NHSCB/A09/PS/b

Atrial Fibrillation and Heart Failure: A Cause or a Consequence

Electrocardiographic Issues in Williams Syndrome

How do you decide on rate versus rhythm control?

Fellow TEE Review Workshop Hemodynamic Calculations Director, Intraoperative TEE Program. Johns Hopkins School of Medicine

Dr Richard Telford. Introduction

Atrial Fibrillation An update on diagnosis and management

GERIATRYCZNE PROBLEMY KLINICZNE/GERIATRICS MEDICAL PROBLEMS

Hot Topics: Current PFO Recommendations and Loop Monitoring/Cryptogenic Stroke.

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

Non-Invasive Risk Predictors in (Children with) Pulmonary Hypertension

Guidelines on the management of valvular heart disease

Heart valve repair and replacement

5. Diagnosis and management of rheumatic heart disease

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History

How should we treat atrial fibrillation in heart failure

Workshop B: Essentials of Neonatal Cardiology and CHD Anthony C. Chang, MD, MBA, MPH CARDIAC INTENSIVE CARE

Normal & Abnormal Intracardiac. Lancashire & South Cumbria Cardiac Network

Resuscitation in congenital heart disease. Peter C. Laussen MBBS FCICM Department Critical Care Medicine Hospital for Sick Children Toronto

TAVR: A New Treatment Option for Aortic Stenosis. Alexis Auger, MSN, NP-BC

ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)

Non Invasive Testing for CAD

Hydrodynamic characteristics of prosthetic heart valves Cardiamed

ECG may be indicated for patients with cardiovascular risk factors

Exchange solutes and water with cells of the body

CARDIAC RISKS OF NON CARDIAC SURGERY

Aortic Stenosis and Comorbidities: the clinical challenge. P. Faggiano Cardiology Division Spedali Civili, Brescia - Italy

Diagnosis Code Crosswalk : ICD-9-CM to ICD-10-CM Cardiac Rhythm and Heart Failure Diagnoses

Anatomi & Fysiologi The cardiovascular system (chapter 20) The circulation system transports; What the heart can do;

Congestive heart failure (CHF) is a. Diastolic Heart Failure. By Michel D Astous, MD, FRCPC

Heart Disease: Diagnosis & Treatment

Specific Basic Standards for Osteopathic Fellowship Training in Cardiology

The Difficult Mitral Valve Repair in Children, Leave with Stenosis or Regurgitation

Pre-Operative Cardiac Evaluation Kalpana Jain, MD

Mitral Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation. Michael Acker, MD For the CTSN Investigators AHA November 2013

Question 1: Interpret the rhythm strip above (comment on regularity, rate, P wave, PR interval and QRS)?

Mitral valve repair current Status and the modern Sternotomy

2/20/2015. Cardiac Evaluation of Potential Solid Organ Transplant Recipients. Issues Specific to Transplantation. Kidney Transplantation.

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

1 Congestive Heart Failure & its Pharmacological Management

Focused Transthoracic Echocardiography by Sports Medicine Physicians

Carcinoid Hjärtsjukdom

Atrial fibrillation. Quick reference guide. Issue date: June The management of atrial fibrillation

Acute heart failure may be de novo or it may be a decompensation of chronic heart failure.

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES.

National Imaging Associates, Inc. Clinical guidelines

Equine Cardiovascular Disease

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

Teaching Med-5 Students Point-of-Care Transthoracic Echocardiography

Madeline M. Mimi O Donnell, DNP, RN (W) (617) modonnell@mghihp.edu

How do you decide on rate versus rhythm control?

CTA OF THE EXTRACORONARY HEART

BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY

Anaesthesia and Heart Failure

on behalf of the AUGMENT-HF Investigators

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF)

Management of ATRIAL FIBRILLATION. in general practice. 22 BPJ Issue 39

Cardiovascular Guidelines for DOT Physical Exams By Maureen Collins MSN, APRN, BC

Objectives. The ECG in Pulmonary and Congenital Heart Disease. Lead II P-Wave Amplitude during COPD Exacerbation and after Treatment (50 pts.

The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It?

Read It, Code It, See It

Auscultation of the Heart

Transcription:

Sport and Aortic valve disease JESFC 2014 Frédéric SCHNELL Service de Médecine du Sport CHU Rennes Laboratoire de Physiologie Université Rennes 1 INSERM U 1099

Prevalence in athletes? Valvular regurgitation more frequent in athletes At least one regurgitant > 90% ; 3-valve regurgitation in 20% Majority = trivial regurgitant volume => no clinical significance Douglas PS, Prevalence of multivalvular regurgitation in athletes. Am J Cardiol, 1989 Aortic Stenosis 2.5 % sudden death in young athletes Maron, The Heart of Trained Athletes, Circ 2006 Bicuspide Valve Same prevalence as in general population = 2.5% Stefani L, Bicuspid aortic valve in competitive athletes, Br J Sports Med 2008

Risks of sport in valvular disease? Little is known about the influence of sport on the progression of valvular disease Increase of cardiac output at exercise progression of the valvulopathy? no current scientific data Brutal hemodynamic inadaptation at exercise Arrhythmia Desadaptation of the cardiac pump Parker MW, exercise in valvular heart disease: risks and benefits. Prog Cardio Dis 2011

Mellwig, Recommendations for the management of individuals with acquired valvular heart disease who are involved in leissure-time physical activities or competitive sports, EurCardPrev Rehab 2008 Severity? Clinical, ECG, echocardiography ACC AHA guidelines for the management of patients with valvular heart disease, JACC 2006 Vahanian, Guidelines on the management of valvular Heart Disease, Eur Heart J 2007 + Athlete: CPET / exercise echo ± Holter-ECG Intensity? Competitive/leissure-time Mitchell sport classification Recommendations for sports participation Maron, 36th Bethesda conference, Eligibility Recommendations for competitive athletes with cardiovascular abnormalities, JACC 2005 Pelliccia, Recommendations for competitive sports participation in athletes with cardiovascular disease, EHJ 2005

Bicuspid aortic valve Prevalence = 2.5% Valvular Complications : Aortic Stenosis Aortic Regurgitation Aortic dilatation: > 20-21mm/m 2 Disorders of vascular connective tissue «Recommendations are based on limited data but with the understanding that aortic dissection can occur with aortic root diameters < 50 mm» Stefani L, Bicuspid aortic valve in competitive athletes, Br J Sports Med 2008 Maron, 36th Bethesda conference, JACC 2005

Bicuspid aortic valve Criteria for eligibility Recommendations Follow-up no aortic root dilatation < 40 mm* + no significant AS or AR dilated aortic root 40-45 mm ** all competitive sports classes IA, IB, IIA, and IIB No sports with potential for body collision or trauma 6 months dilated aortic root > 45 mm *** class IA 6 months * < 21 cm/m 2 ; ** 21 23.5mm/m 2 ; *** > 23.5 mm/m 2 Multimodality imaging for the Aorta: CT, MRI Maron, 36th Bethesda conference, Eligibility Recommendations for competitive athletes with cardiovascular abnormalities, JACC 2005

Aortic regurgitation Asymptomatic for many years Sudden death rare among asymptomatic patients (<0.2%/year) Unclear how competitive exercise training affects prognosis: Dynamic exercises acutely increases heart rate = shortens diastole time available for aortic regurgitation regular endurance training induces bradycardia = prolongs AVR and may induce LV dysfunction Static exertion can worsen regurgitation by increasing afterload acutely Carabello BA. Progress in mitral and aortic regurgitation. Curr Probl Cardiol 2003;28:549 84. ACC AHA guidelines for the management of patients with valvular heart disease, JACC 2006

Aortic regurgitation Evaluation Criteria for eligibility Recommendations Follow-up History, PE, ECG, ET, Echo Mild-to-moderate regurgitation, normal LV size and function, normal exercise testing, no significant arrhythmia Mild-to-moderate regurgitation, proof of progressive LV dilatation Mild-to-moderate regurgitation, significant ventricular arrhythmia at rest or under stress AVR and dilatation of the ascending aorta (>50mm) All sports Class IA No competitive sports No competitive sports 6 months Severe regurgitation No competitive sports Mild=absence of peripheral signs of AVR and normal LV -and atrial size and function; small dimension of the diastolic flow signal on Doppler echocardiography. Moderate=peripheral signs of AVR, mild-to-moderate enlargement of the LV, normal systolic function, moderate dimension of the diastolic flow signal on Doppler echo. Severe=peripheral signs of AVR, marked dilatation of the LV and/or evidence of LV dysfunction; enlarged atrial size and large dimension of the diastolic flow signal on Doppler echo Mellwig, Recommendations for the management of individuals with acquired valvular heart disease who are involved in leissure-time physical activities or competitive sports, Eur Card Prev Rehab 2008

Aortic regurgitation Evaluation: Pitfalls in athletes LV end-diastolic size is increased in the healthy athlete => should be considered when assessing LV size in AR Professional Rugby Player H= 1.95m - W=123kg BSA=2,54m 2 LVDd: 23,7 mm/m 2 LVEDd: 60mm - LVESd 42mm

Aortic Stenosis Sudden death is more frequent in symptomatic patients with severe AS May occur in completely asymptomatic patients Is rare with mild AS Present in 2.5% of young athletes with SCD In patients with AS exercise induces a markedly elevated cardiac output or peripheral vascular resistance => exaggerated valvular gradient and a marked increase in LV systolic pressure Rosenhek R, Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000 Maron, The Heart of Trained Athletes : Cardiac Remodeling and the Risks of Sports, Including Sudden Death Cir 2006

Aortic Stenosis Evaluation Criteria for eligibility Recommendations Follow-up History, PE, ECG, ET, Echo Mild stenosis normal LV size and function at rest and under stress no symptoms, no significant arrhythmia Low-moderate dynamic, low-moderate static (I A,B + II A, B) Moderate stenosis normal LV function at rest and under stress Low dynamic and low static (IA) Moderate stenosis LV dysfunction at rest or under stress, or marked LV hypertrophy (>15 mm) No competitive sports Severe stenosis No competitive sports Symptomatic patients with significant AVS Surgery Mild=AVA > 1.5 cm 2, mean gradient 20mmHg / Moderate=AVA of 1.0 1.5 cm 2, mean gradient 21 49 mmhg / Severe=AVA <1.0 cm 2, mean gradient 50mmHg. Mellwig, Recommendations for the management of individuals with acquired valvular heart disease who are involved in leissure-time physical activities or competitive sports, Eur Card Prev Rehab 2008

Aortic Prosthesis Insufficient data to determine whether sport has any longlasting effect on ventricular or prosthetic valve function Reduced effective valve areas Exercise: elevated valve gradients and reduced cardiac outputs / normally expected Evaluate at rest and during exercise using stress echo to the level of exercise the athlete wishes to pursue Maron, 36th Bethesda conference, Eligibility Recommendations for competitive athletes with cardiovascular abnormalities, JACC 2005 Mellwig, Recommendations for the management of individuals with acquired valvular heart disease who are involved in leissure-time physical activities or competitive sports, Eur Card Prev Rehab 2008

Aortic Prosthesis Ao valve Evaluation Criteria for eligibility Recommendations Followup Bioprosthetic History, PE, ECG, ET, Echo Normal valve function + normal LV function + stable sinus rhythm I A,B + II A, B AF and anticoagulation + No contact sports Prosthetic (artificial) Normal valve function + normal LV function + anticoagulation I A,B + II A, B No contact types of sport Mellwig, Recommendations for the management of individuals with acquired valvular heart disease who are involved in leissure-time physical activities or competitive sports, Eur Card Prev Rehab 2008

Conclusion «Physicians with knowledge of an individual athlete severity of the lesion + physiological + psychological response to competition may liberalize these recommendations in selected instances» «The recommendations are for athletes who are asymptomatic» «Exercise testing is useful in confirming normal effort tolerance and suitability for the proposed athletic activity»